Contributions
287 recent contributions in Hansard
HANSARDGreat British Energy BillI see the point the noble Lord is making, but that is a matter for the board. I have a certain degree of faith in the Secretary of State and we have an extremely competent chair…03 Dec 2024HANSARDGreat British Energy BillI have answered the noble Baroness’s question to the best of my ability; I will write to her.03 Dec 2024HANSARDGreat British Energy BillYes, it is within the £8.3 billion.03 Dec 2024HANSARDGreat British Energy BillAs far as I know, the answer to that question is yes. That is to the best of my knowledge. If it is not, I will have to write to the noble Baroness.03 Dec 2024HANSARDHuman Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2024That the draft Regulations laid before the House on 21 October be approved. Relevant document: 6th Report from the Secondary Legislation Scrutiny Committee. Considered in Grand…02 Dec 2024HANSARDMedical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024My Lords, I am grateful to be here to debate these important regulations, which herald a much-needed shift in the way we manage medical devices in Britain. This draft statutory…28 Nov 2024HANSARDHuman Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2024That the Grand Committee do consider the Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2024. Relevant document: 6th Report from the Secondary…28 Nov 2024HANSARDHuman Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2024I am grateful to the noble Lord for both his contribution and his welcome. He can tell that I am still shuffling papers around. I suppose that there are always unintended…28 Nov 2024HANSARDHuman Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2024My Lords, I beg to move that the Committee consider this amendment to the Human Medicines Regulations 2012 and the Medicines for Human Use (Clinical Trials) Regulations 2004. I am…28 Nov 2024HANSARDMedical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024That the Grand Committee do consider the Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024. Relevant document: 6th Report from…28 Nov 2024HANSARDMedical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024I am very grateful to the noble Lord for his comments. The Committee will not know, but he mentioned to me beforehand that he might raise products from other jurisdictions and…28 Nov 2024HANSARDMedical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024A process of consultation has been ongoing for quite a while. It has been done in a very constructive way on all sides, I hope, and certainly on the UK side. I will write to the…28 Nov 2024HANSARDMental Health Bill [HL]Let me just point out that the limit of nine minutes is voluntary, but a lot of people want to speak.25 Nov 2024HANSARDFarming FamiliesI apologise for interrupting the debate, but I gently remind all noble Lords that the speaking limit is three minutes. If noble Lords go well over that, we will eat into the time…21 Nov 2024HANSARDNHS: Anti-obesity MedicationI recognise my noble friend’s interest in this issue. The National Institute for Health and Care Excellence—NICE—makes recommendations on whether new medicines, including obesity…18 Nov 2024HANSARDNHS: Anti-obesity MedicationI recognise the noble Lord’s distinguished history, and again he touches on a range of issues. I will say just a couple of things. The idea that the drugs are licensed and…18 Nov 2024HANSARDNHS: Anti-obesity MedicationI appreciate what the noble Lord says but, again, the processes that lead to drugs becoming available on the NHS are extremely rigorous. The noble Lord seemed to imply, or he…18 Nov 2024HANSARDNHS: Anti-obesity MedicationI am grateful to the noble Lord, who makes a number of good points. He is mainly talking about the MHRA and NICE. The MHRA continuously works with national and international…18 Nov 2024HANSARDNHS: Anti-obesity MedicationI am very grateful to the noble Lord. Of course, I will always give him the answers that he seeks. He touches on a lot of issues there—his question alone is probably worth a QSD.…18 Nov 2024HANSARDNHS: Anti-obesity MedicationI am grateful for the question. What the right reverend Prelate is really talking about is conditions rather than medicine, which touches on an important part of the 10-year plan…18 Nov 2024